Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Retension Pharmaceuticals Inc.

Retension Pharmaceuticals Inc. (RTSN) Stock Overview

Explore Retension Pharmaceuticals Inc.’s financial performance, market position, analyst ratings, and future outlook.

RTSN●NASDAQ
HealthcareMedical - Pharmaceuticals
$12.15
$0.13(1.08%)
U.S. Market opens in 3h 1m

Retension Pharmaceuticals Inc. (RTSN)

Meyka AI Score

Z

Key Financials

Market Cap45.6M
P/E RatioN/A
EPS (TTM)$-2.61
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 Month$12.51
3 Months$0.00
1 Year Target$0.00

RTSN Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Retension Pharmaceuticals Inc. (NASDAQ: RTSN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Retension Pharmaceuticals Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of RTSN on the NASDAQ shows an RSI of 49.32, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Retension Pharmaceuticals Inc.'s NASDAQ-traded stock include a P/E ratio of N/A and a market capitalization of 45.6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of RTSN on the NASDAQ.

Price Performance (NASDAQ: RTSN)

1-Day Change
1.08%
5-Day Change
14.41%
1-Month Change
15.38%
3-Month Change
15.38%
6-Month Change
15.38%
Year-to-Date (YTD) Change
15.38%
1-Year Change
15.38%
3-Year Change
15.38%
5-Year Change
15.38%
All-Time (Max) Change
15.38%

Contact Information

http://www.retensionpharmaceuticals.com
NaN
1104 West Broad Street 1029, Falls Church, VA, 22046

Company Facts

120 Employees
IPO DateOct 9, 2026
CountryUS
Actively Trading

Frequently Asked Questions